BioSpace News Archive

Novel Oral Plasma Kallikrein Inhibitors KV998052 and KV998054 Prevent and Reverse VEGF-Induced Retinal Edema in Mice

Approval based on results from clinical studies showing high rates of skin clearance at 16 weeks; this clearance was durable at one year with every 12-week dosing

SDM Northcoast is excited to announce major improvements to its service offering.

The Blue Cross Blue Shield Association and Blue Health Intelligence® invite visionary companies to enter the BlueCross BlueShield Data Innovation Challenge to develop solutions that increase access to care, enhance patient engagement, and improve care delivery and outcomes.

Qpex Biopharma announced the closing of a license agreement from Monash University providing Qpex a portfolio of next-generation polymyxin antimicrobials focused against highly drug-resistant gram-negative pathogens.

Phoenix Tissue Repair, Inc. announced that the U.S. Food and Drug Administration has granted fast track designation for PTR-01, an investigational protein replacement therapy designed to treat recessive dystrophic epidermolysis bullosa.

Aldeyra Therapeutics, Inc. announced that the last patient has completed dosing in the SOLACE Phase 3 clinical trial of topical ocular reproxalap in patients with noninfectious anterior uveitis.

Genomic Health, Inc. announced that the company will host a conference call and webcast on Tuesday, May 7 at 4:30 p.m. Eastern Time to discuss its first quarter 2019 financial results.

EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that Dr. Mary Norine “Minnow” Walsh has become Co-Principal Investigator (Co-PI) of the SOLVE CRT clinical study.

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases, will host a conference call and webcast to report its first quarter 2019 financial results and provide a corporate update on Tuesday, May 7, 2019.